CHELSEA BAIRD: Open Payments
NPI 1770360836 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $132 |
| Integra LifeSciences Corporation | 2 | $46 |
| TREACE MEDICAL CONCEPTS, INC. | 1 | $42 |
| Bioventus LLC | 2 | $38 |
| PolyNovo North America LLC | 1 | $35 |
| Orthofix Medical, Inc. | 2 | $32 |
| Kerecis Limited | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
Products named: JOURNAVX, Integra, TMC SPEEDTMT, EXOGEN ULTRASOUND BONE HEALING SYSTEM, NOVOSORB BTM, Physio-Stim, Kerecis SurgiClose, Exparel.
Industry payments across NE — which companies pay providers there.
